Aldevron announced today its new fermentation capacity of 1,000 liters and plans to significantly increase the Company’s manufacturing footprint in Madison, WI. The large-scale fermentation equipment is already installed and will be coming on-line in Q4 2019. The new fermentation capacity will support gene and cell therapy studies that require large amounts of plasmid DNA, […]
A program launched last year by the Wisconsin Alumni Research Foundation to invest in promising biotech discoveries made on the University of Wisconsin-Madison campus will also work with the La Jolla, CA-based Sanford Burnham Prebys Medical Discovery Institute, the organizations said recently. The partnership is part of a broader movement to accelerate the “bench to bedside” process […]
Madison biopharmaceutical company Dianomi Therapeutics has raised $3 million in funding following a partnership with publicly traded drug company Ligand Pharmaceuticals. Dianomi announced Tuesday that Ligand invested $3 million in the startup in exchange for a royalty of two or three percent based on net sales for Dianomi’s first five products developed using its technology. Ligand will also provide […]
MADISON – Wisconsin’s early-stage health and life science firms and the Center for Technology Commercialization (CTC) received national attention for the state’s success over the past decade in landing competitive federal grants. Wisconsin ranked third after Oregon and Vermont in securing Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding from the […]
BioForward, Wisconsin’s state association representing over 200 biohealth member companies, announced three additions to this year’s Board of Directors. The board represents many facets of the state’s diverse biohealth industry and focuses on advocating for Wisconsin’s strengths in development of integrated health solutions and academic research.Newly elected Board Members for the 2019-21 term include: Jon […]
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has commenced a $200 million capital investment in its Biologics business to expand drug substance manufacturing capacity and drug product fill/finish capacity due to projected growth among existing and future […]
By the time he was diagnosed with metastatic melanoma, Luke Simons, now 83, had already watched his wife and his longtime business partner struggle with cancer. His wife had chemo for her breast cancer 20 years ago. His business partner with multiple myeloma died 5 years ago. “I was obviously aware of what it could […]
Fujifilm Cellular Dynamics Inc. (FCDI) plans to invest $21 million to create a facility in Madison’s University Research Park for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue. Full Article available on Wisconsin State Journal
Agreement provides Sarepta with committed capacity and dedicated manufacturing slots for GMP-grade plasmid production for its micro-dystrophin Duchenne muscular dystrophy (DMD) gene therapy program, as well as plasmid capacity for future gene therapy programs Full Release available here